एपीए उद्धरण

Leiting, J. L., Hernandez, M. C., Yang, L., Bergquist, J. R., Ivanics, T., Graham, R. P., & Truty, M. J. (2019). Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts. Sci Rep.

शिकागो स्टाइल उद्धरण

Leiting, Jennifer L., Matthew C. Hernandez, Lin Yang, John R. Bergquist, Tommy Ivanics, Rondell P. Graham, और Mark J. Truty. "Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts." Sci Rep 2019.

एमएलए उद्धरण

Leiting, Jennifer L., et al. "Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts." Sci Rep 2019.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.